Guilin Sanjin Pharmaceutical Co Ltd (002275) — Cash Flow Reinvestment Rate
Guilin Sanjin Pharmaceutical Co Ltd (002275) has a Cash Flow Reinvestment Rate of 1.06x as of September 2025, reinvesting CN¥124.26 Million (capex CN¥124.26 Million ) from operating cash flow of CN¥117.62 Million. Explore 002275 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Guilin Sanjin Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2006–2024)
Historical reinvestment intensity for Guilin Sanjin Pharmaceutical Co Ltd across 19 annual periods. Also explore total assets of Guilin Sanjin Pharmaceutical Co Ltd for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Guilin Sanjin Pharmaceutical Co Ltd (2006–2024)
Year-by-year capital reinvestment analysis for Guilin Sanjin Pharmaceutical Co Ltd. For live market cap and broader valuation context, see Guilin Sanjin Pharmaceutical Co Ltd market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.60x | CN¥355.43 Million | CN¥588.33 Million | CN¥82.18 Million | ▲ +94.5% |
| 2023 | 0.31x | CN¥170.62 Million | CN¥549.25 Million | CN¥76.40 Million | ▲ +37.2% |
| 2022 | 0.23x | CN¥119.74 Million | CN¥528.67 Million | CN¥62.27 Million | ▼ -49.5% |
| 2021 | 0.45x | CN¥184.03 Million | CN¥410.24 Million | CN¥144.09 Million | ▲ +17.2% |
| 2020 | 0.38x | CN¥228.91 Million | CN¥597.99 Million | CN¥205.47 Million | ▼ -73.6% |
| 2019 | 1.45x | CN¥678.71 Million | CN¥468.29 Million | CN¥226.14 Million | ▲ +122.8% |
| 2018 | 0.65x | CN¥358.96 Million | CN¥551.73 Million | CN¥89.96 Million | ▲ +15.1% |
| 2017 | 0.57x | CN¥219.27 Million | CN¥387.82 Million | CN¥61.53 Million | ▼ -4.6% |
| 2016 | 0.59x | CN¥318.27 Million | CN¥536.85 Million | CN¥65.36 Million | ▼ -8.9% |
| 2015 | 0.65x | CN¥259.42 Million | CN¥398.50 Million | CN¥125.02 Million | ▲ +22.2% |
| 2014 | 0.53x | CN¥211.28 Million | CN¥396.53 Million | CN¥211.28 Million | ▼ -46.5% |
| 2013 | 1.00x | CN¥312.85 Million | CN¥314.16 Million | CN¥312.85 Million | ▲ +46.5% |
| 2012 | 0.68x | CN¥205.63 Million | CN¥302.59 Million | CN¥205.63 Million | ▲ +82.9% |
| 2011 | 0.37x | CN¥126.75 Million | CN¥341.05 Million | CN¥126.75 Million | ▲ +7.8% |
| 2010 | 0.34x | CN¥98.44 Million | CN¥285.49 Million | CN¥98.44 Million | ▲ +129.1% |
| 2009 | 0.15x | CN¥54.68 Million | CN¥363.29 Million | CN¥54.68 Million | ▼ -25.6% |
| 2008 | 0.20x | CN¥38.64 Million | CN¥190.97 Million | CN¥38.64 Million | ▲ +89.1% |
| 2007 | 0.11x | CN¥17.59 Million | CN¥164.39 Million | CN¥17.59 Million | ▼ -20.1% |
| 2006 | 0.13x | CN¥29.16 Million | CN¥217.67 Million | CN¥29.16 Million | — |